Pharmazz is a privately held company developing novel products in critical care medicine. The U.S. Food and Drug Administration (FDA) has approved two phase III INDs for Centhaquine as an agent for hypovolemic shock and Sovateltide for cerebral ischemic stroke. In addition, Pharmazz obtained marketi...See more
Headquarters:
Vietnam
Company Type:
SME
Company size:
51-200 Employees
Year Founded:
2010 (15 years)
Address:
50 WEST 75TH STREET; SUITE 105 WILLOWBROOK; IL, 60527, US
HIGH
spending power
